Stock data
Unicycive Therapeutics, Inc. (UNCY)
Unicycive Therapeutics, Inc. (UNCY) reported net income of -US$26.55M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$29.52M | -US$26.55M | — |
| 2024 | — | — | -US$32.12M | -US$36.73M | — |
| 2023 | US$0.68M | — | -US$20.77M | -US$30.54M | — |
| 2022 | US$0.95M | — | -US$18.05M | -US$18.06M | — |
| 2021 | — | — | -US$8.98M | -US$10.02M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$1.72M | — |
| 2026-03-31 | — | -US$12.82M | — |
| 2025-12-31 | — | -US$14.67M | — |
| 2025-09-30 | — | -US$6.01M | — |
| 2025-06-30 | — | -US$6.45M | — |
| 2025-03-31 | — | US$0.57M | — |
| 2024-12-31 | — | -US$21.52M | — |
| 2024-09-30 | — | -US$4.10M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.